quetiapine

(redirected from Seroquel XR)
Also found in: Dictionary.

quetiapine

 [kwĕ-ti´ah-pēn]
a serotonin and dopamine antagonist used as the fumarate salt as an antipsychotic agent; administered orally.

quetiapine

/que·ti·a·pine/ (kwĕ-ti´ah-pēn) a serotonin and dopamine antagonist used as the fumarate salt as an antipsychotic.

quetiapine

(kwə-tī′ə-pēn′)
n.
An antipsychotic drug, C21H25N3O2S, that acts as an antagonist of multiple neurotransmitters including serotonin and norepinephrine and is used in its fumarate form to treat schizophrenia and bipolar disorder.

quetiapine

an antipsychotic/neuroleptic.
indications It is used in the treatment of psychotic disorders.
contraindication Known hypersensitivity to this drug prohibits its use.
adverse effects Life-threatening effects are seizures, neuroleptic malignant syndrome, and tachycardia. Other adverse effects include extrapyramidal symptoms, pseudoparkinsonism, akathisia, dystonia, tardive dyskinesia, drowsiness, insomnia, agitation, anxiety, orthostatic hypotension, abdominal pain, dry mouth, rhinitis, rash, asthenia, back pain, fever, and ear pain. Common side effects include headache, dizziness, nausea, anorexia, and constipation.

quetiapine

A dibenzothiazepine antipsychotic drug used to treat SCHIZOPHRENIA. A brand name is Seroquel.
References in periodicals archive ?
Report provides a overview on following product profiles: Lexapro (Escitalopram), Viibryd (Vilazodone), Effexor (Venlafaxine), Cymbalta (Duloxetine), Pristiq (Desvenlafaxine), Fetzima (Levomilnacipran), Savella (Milnacipran), Norepinephrine-Dopamine Reuptake Inhibitors, Noradrenaline and Specific Serotonergic Antidepressants, Monoamine Oxidase Inhibitors, Brintellix (Vortioxetine), Tricyclic Antidepressants, Abilify (Aripiprazole), Seroquel XR (Quetiapine).
of Japan, said patients who took Latuda experienced fewer relapses and lower rates of weight gain and other metabolic concerns than patients who took Seroquel XR.
High Court ruled that the patent of Seroquel XR prescription was invalid.
SEROQUEL XR has been developed with the aim of improving dosing and titration options for patients and their doctors as they face the challenge of achieving successful treatment of schizophrenia.
SM], the nation's leader in medication monitoring solutions, today launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug Seroquel XR, one of the 40 best-selling medications in the U.
In depth case study analysis of the numerous lifecycle management strategies used to protect Lipitor, Plavix and Seroquel XR
Seroquel XR (quetiapine) (extended-release tablets) is an atypical antipsychotic that is indicated as an adjunctive treatment for MDD in the US, 5EU, and Australia.
The value of the US market is expected to fall following patent expiries for Eli Lilly's Cymbalta in 2013, Otsuka Pharmaceutical/BMS's Abilify in 2015, and AstraZeneca's Seroquel XR in 2017.
This follows a decision made in the UK on March 22, 2012, which found the formulation patent protecting SEROQUEL XR to be invalid.
The value of the depression market in France is expected to fall following patent expiries for Lundbeck's Lexapro in 2014, Eli Lilly's Cymbalta in 2014, Otsuka Pharmaceutical/BMS's Abilify in 2014, and AstraZeneca's Seroquel XR in 2017.
On September 9, 2011 AstraZeneca filed a Citizen Petition with the FDA for each of SEROQUEL and SEROQUEL XR, requesting the FDA withhold finally approving any generic quetiapine product that omits from its labeling certain warning language that FDA required AstraZeneca to include in the labeling for SEROQUEL and SEROQUEL XR.
The patent covering the active ingredient in SEROQUEL and SEROQUEL XR expired in September 2011, with pediatric exclusivity expiring on March 26, 2012.